Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial Programme.

Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial Programme. J Crohns Colitis. 2024 May 31; 18(5):695-707.

View in: PubMed

subject areas

Adrenal Cortex Hormones
Adult
Colitis, Ulcerative
Double-Blind Method
Female
Heterocyclic Compounds, 3-Ring
Humans
Male
Middle Aged
Severity of Illness Index
Treatment Outcome

authors with profiles

David T. Rubin